An Implementation Science Study Investigating Profiles of Men Interested in MMC (Imbizo)

January 27, 2016 updated by: The Aurum Institute NPC

An Implementation Science Study Investigating Profiles of Men Interested in Medical Male Circumcision (MMC), Barriers and Methods to Increase the Uptake of MMC Among Older Men in South Africa

There are both supply and demand gaps in our understanding of how best to implement MMC services. In terms of supply of MMC services, there is a need to better understand what the best way is of efficiently accessing mature men(25-49 years old) . The investigators also want to understand the type of service delivery approach and environment that would make mature men(25-49 years old) feel more comfortable when attending an MMC clinic. Demand of MMC requires identifying messaging that works to address mature men's (25-49 years old) issues so that they might be willing to undergo MMC. To further advance HIV prevention and advocacy of male circumcision the investigators also need to consider the perspectives of women on what approach MMC messaging should take. A combination of male and female viewpoints could inform MMC outreach messaging where IEC materials are tailored to address the barriers to MMC. Identifying the specific barriers to MMC among males and including the perspectives

Study Overview

Status

Completed

Detailed Description

Part I (Formative Period) Given these issues, in addition to establishing a baseline estimate of the ages and risk behaviours of males currently undergoing MMC at the Aurum clinic over a six month period, we include a qualitative research component. We conducted research in 2014 to establish a baseline estimate of the ages and risk behaviours of males undergoing MMC at the Aurum clinic over a six month period. The baseline estimate (Ethics reference number M130711) will be referred to as the formative Part I. The formative Part I includes a quantitative and qualitative research component. The qualitative component will include both genders and be used to develop MMC recruitment messaging tailored to mature men(25-49 years old) . Men will provide their opinion on circumcision and on what type of marketing message they feel will encourage mature men (25-49 years old) to be circumcised. Women will also provide their perspectives on male circumcision and what messaging could be used to encourage their partners or male family members to be circumcised. During this study, we explored if women have a role in promoting male circumcision to their partners, family and the community. These qualitative findings will be used to develop interventions to increase the ratio of men (25-49 years old) mature, or at least of higher risk men, undergoing MMC at the clinic. These interventions and the outcomes related to them will be presented as an amendment to this protocol after the baseline and qualitative data are collected and analysed.

Part II (Intervention Period) Findings from the formative period will be used to develop interventions to increase the ratio of men (25-49 years)mature, or at least of higher risk men, undergoing MMC at the clinic. During this proposed intervention period we would like to evaluate the effectiveness of those interventions and the outcomes related to them. These proposed interventions will directly address the barriers to MMC that challenge uptake of MMC among mature men (25-49 years). Additionally, epidemiologic research will be conducted among men attending our MMC clinic to evaluate whether mature men (25-49 years) exhibit, as is presumed, higher risk profiles for HIV. We will also explore the cost-effectiveness of this strategy.

Study Type

Observational

Enrollment (Actual)

2817

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Gauteng, South Africa, 1632
        • The Aurum Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Males 18 and above accessing medical male circumcision services in Ekurhuleni North, South Africa

Females 18 and above who live in the vicinity of Ekurhuleni North, South Africa

Description

Inclusion Criteria for Cross Sectional Component Inclusion Criteria:

All males who meet the following criteria will be eligible for inclusion:

  • Are aged 18 years or older (no upper age limit)
  • Have never been completely medically circumcised (as opposed to partial circumcision)
  • Willing and able to give their written informed consent so that the information collected during the clinic visit can be analysed for research purposes.

Inclusion Criteria Qualitative Component for males

All males who meet the following criteria will be eligible for inclusion:

  • Present at Aurum's male circumcision clinic during the cross sectional component or men who indicate no interest in medical male circumcision
  • Are between the ages of 25 and 49 inclusive
  • Are not circumcised at the time of the interview as assessed through visual examination
  • Is willing and able to provide written informed consent.
  • Willing for the qualitative session to be tape recorded

Inclusion Criteria for Qualitative Component for females Women who meet the following criteria will be eligible for inclusion

  • Are 18 and above (no upper age limit)
  • Has a partner who is participating in the cross sectional component, is not in a relationship but lives in the vicinity of Ekurhuleni North district or is part of a women's organization within the community where the clinic is located
  • Is willing and able to provide written informed consent
  • Willing for the qualitative session to be tape recorded

Inclusion Criteria Part II (Intervention Period) Inclusion Criteria for the "Exclusive Intervention Strategy" Men who meet the following criteria will be eligible for inclusion in the intervention period

  • Are between the ages 25 and 49 years inclusive
  • Has never been medically circumcised
  • Is willing and able to provide written informed consent

Inclusion Criteria for the "Active Follow-up Intervention" Men who meet the following criteria will be eligible for inclusion

  • Are between the ages 25 and 49 years inclusive
  • Has never been medically circumcised
  • Is willing and able to provide written informed consent
  • Has contra-indication/s to MMC on the day of presentation for MMC
  • Is willing to provide contact information for retention

Exclusion Criteria for all Aims:

  • Men who are unable to communicate sufficiently (in English or local languages) to complete medical forms and/or research questionnaires for the cross sectional component.
  • Men and women who do not in the opinion of staff obtaining consent have the capacity to provide written informed consent will be excluded from the research.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Current proportion of mature men (25-49 years) presenting for and undergoing MMC
Time Frame: 6 months
To describe the current proportion of mature men (25-49 years) presenting for and undergoing MMC compared to all men (18 and above) during a 6 month period when routine service delivery and outreach messaging will be employed at one Aurum site.
6 months
Particular barriers to MMC among men (25-49 years)
Time Frame: 6 months
To describe the particular barriers to MMC among men (25-49 years) regardless of circumcision status, develop tailored messaging and outreach materials promoting MMC to mature men.
6 months
Barriers to MMC and using the perspective of women
Time Frame: 6 months
To investigate the particular barriers to MMC and using the perspective of women develop tailored messaging and outreach materials promoting MMC to mature men.
6 months
Effectiveness of offering an "Exclusive Intervention Strategy"
Time Frame: 6 months
Evaluate the effectiveness of offering an "Exclusive Intervention Strategy" comprised of customized services to mature (25-49 years) men. To achieve this aim we will compare the proportion of mature men (25-49 years) presenting for MMC during the formative and intervention periods.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Risk behaviours
Time Frame: 6 months
Identify risk behaviours (e.g. multiple partners; inconsistent condom use and STI symptoms) of men currently presenting at the Aurum MMC clinic.
6 months
Compare risk behaviours to national prevalence
Time Frame: 6 months
Compare risk behaviours of men presenting for MMC with that of national prevalence estimates of risk behaviour.
6 months
Risk profile, age and source of recruitment
Time Frame: 6 months
Describe the risk profile, age and sources of recruitment of men presenting at the clinic. To achieve this aim we will examine each of these factors over time.
6 months
Factors associated with the intervention
Time Frame: 6 months
Identify whether the intervention is associated with HIV risk behaviours (for example multiple partners), having adjusted for age. This is to identify if the intervention has resulted in men attending for MMC with a different risk profile over and above any anticipated age differences.
6 months
Socio-demographic factors
Time Frame: 6 months
Identify socio-demographic factors associated with HIV risk behaviours, among mature men (25-49 years).
6 months
Effectiveness of active follow-up
Time Frame: 6 months
Evaluate the effectiveness of an active follow-up system on completion of MMC among mature men (25-49 years) who present for MMC but who are initially referred for care due to contra-indication to MMC
6 months
Cost effectiveness
Time Frame: 6 months
To determine the cost-effectiveness of this intervention among mature men (25-49 years).
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Salome Charalambous, MBBCH, PhD, Aurum Institute

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2014

Primary Completion (ACTUAL)

November 1, 2015

Study Completion (ACTUAL)

December 1, 2015

Study Registration Dates

First Submitted

January 28, 2015

First Submitted That Met QC Criteria

January 30, 2015

First Posted (ESTIMATE)

February 2, 2015

Study Record Updates

Last Update Posted (ESTIMATE)

January 28, 2016

Last Update Submitted That Met QC Criteria

January 27, 2016

Last Verified

January 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • AUR2-4-121

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Publications will be shared and made available

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Medical Male Circumcision

Clinical Trials on Exclusive Intervention Strategy

3
Subscribe